Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
$117.41
-4.6%
$113.84
$73.12
▼
$126.40
$103.32M1.2510,652 shs6,086 shs
KURE
KraneShares MSCI All China Health Care Index ETF
$18.30
-0.8%
$18.40
$14.38
▼
$19.93
$112.55M0.2952,172 shs21,252 shs
LFSC
F/m Emerald Life Sciences Innovation ETF
$45.07
-2.8%
$44.00
$32.84
▼
$48.78
$125.75M0.964,549 shs12,779 shs
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
$72.01
-1.3%
$62.77
$42.76
▼
$75.69
$116.66M1.0511,650 shs5,992 shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
+0.55%-1.58%+13.16%+14.44%+63.30%
KURE
KraneShares MSCI All China Health Care Index ETF
-1.55%-0.97%-0.16%-1.13%-3.35%
LFSC
F/m Emerald Life Sciences Innovation ETF
0.00%+1.67%+10.37%-0.96%+34.17%
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
+0.10%-0.98%+19.73%+23.67%+47.67%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
$117.41
-4.6%
$113.84
$73.12
▼
$126.40
$103.32M1.2510,652 shs6,086 shs
KURE
KraneShares MSCI All China Health Care Index ETF
$18.30
-0.8%
$18.40
$14.38
▼
$19.93
$112.55M0.2952,172 shs21,252 shs
LFSC
F/m Emerald Life Sciences Innovation ETF
$45.07
-2.8%
$44.00
$32.84
▼
$48.78
$125.75M0.964,549 shs12,779 shs
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
$72.01
-1.3%
$62.77
$42.76
▼
$75.69
$116.66M1.0511,650 shs5,992 shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
+0.55%-1.58%+13.16%+14.44%+63.30%
KURE
KraneShares MSCI All China Health Care Index ETF
-1.55%-0.97%-0.16%-1.13%-3.35%
LFSC
F/m Emerald Life Sciences Innovation ETF
0.00%+1.67%+10.37%-0.96%+34.17%
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
+0.10%-0.98%+19.73%+23.67%+47.67%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
2.63
Moderate Buy$117.41N/A
KURE
KraneShares MSCI All China Health Care Index ETF
0.00
N/AN/AN/A
LFSC
F/m Emerald Life Sciences Innovation ETF
2.74
Moderate Buy$45.07N/A
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
2.74
Moderate Buy$72.01N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/A
KURE
KraneShares MSCI All China Health Care Index ETF
N/AN/AN/AN/AN/AN/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/AN/AN/AN/AN/AN/A
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/AN/A20.68N/AN/AN/AN/AN/AN/A
KURE
KraneShares MSCI All China Health Care Index ETF
N/AN/A22.26N/AN/AN/AN/AN/AN/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/AN/A36.75N/AN/AN/AN/AN/AN/A
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
N/AN/A24.86N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
$0.220.19%N/AN/AN/A
KURE
KraneShares MSCI All China Health Care Index ETF
$0.713.88%N/AN/AN/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/AN/AN/AN/AN/A
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
$0.630.87%N/AN/AN/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/A880,000N/AOptionable
KURE
KraneShares MSCI All China Health Care Index ETF
N/A6.15 millionN/ANot Optionable
LFSC
F/m Emerald Life Sciences Innovation ETF
N/A2.79 millionN/AN/A
ProShares Ultra Health Care stock logo
RXL
ProShares Ultra Health Care
N/A1.62 millionN/ANot Optionable

Recent News About These Companies

(RXL) ProShares Ultra Health Care
PROSHARES ULTRA HEALTH CARE ETFs | Markets Insider
(RXL) Long Term Investment Analysis
(RXL) Investment Analysis
(RXL) On The My Stocks Page
How the (RXL) price action is used to our Advantage
(RXL) Investment Report
YOUR HEALTH: How to spot ultra-processed foods

New MarketBeat Followers Over Time

Media Sentiment Over Time

ProShares Ultra Nasdaq Biotechnology stock logo

ProShares Ultra Nasdaq Biotechnology NASDAQ:BIB

$117.41 -5.72 (-4.65%)
Closing price 03:56 PM Eastern
Extended Trading
$117.44 +0.03 (+0.03%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

KraneShares MSCI All China Health Care Index ETF NYSEARCA:KURE

$18.30 -0.15 (-0.81%)
Closing price 04:10 PM Eastern
Extended Trading
$18.31 +0.01 (+0.05%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares.

F/m Emerald Life Sciences Innovation ETF NASDAQ:LFSC

$45.07 -1.31 (-2.82%)
Closing price 03:56 PM Eastern
Extended Trading
$45.40 +0.33 (+0.73%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

ProShares Ultra Health Care stock logo

ProShares Ultra Health Care NYSEARCA:RXL

$72.01 -0.94 (-1.29%)
Closing price 04:10 PM Eastern
Extended Trading
$72.04 +0.03 (+0.04%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ProShares Ultra Health Care (the Fund) seeks daily investment results that correspond to twice (200%) the daily performance of the Dow Jones U.S. Health Care Index (the Index). The Fund intends to invest at least 80% of its net assets, including any borrowings for investment purposes, under normal circumstances, to equity securities contained in the Index and/or financial instruments that, in combination, have similar economic characteristics. The Fund also intends to invest assets not invested in financial instruments, in debt instruments and/or money market instruments. The Fund intends to concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. ProShare Advisors LLC serves as the investment advisor to the Fund.